Free Trial

Integra LifeSciences (IART) Competitors

Integra LifeSciences logo
$12.69 -0.63 (-4.73%)
Closing price 04:00 PM Eastern
Extended Trading
$12.62 -0.07 (-0.55%)
As of 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IART vs. ITGR, ATEC, ATRC, OFIX, ANGO, SRDX, ARAY, RMTI, RSLS, and ABT

Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), and Abbott Laboratories (ABT). These companies are all part of the "health care equipment" industry.

Integra LifeSciences vs.

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking.

Integer has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

Integer has a net margin of 6.92% compared to Integra LifeSciences' net margin of -0.42%. Integra LifeSciences' return on equity of 12.35% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.92% 11.65% 5.89%
Integra LifeSciences -0.42%12.35%4.82%

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.75B2.43$90.65M$2.1157.59
Integra LifeSciences$1.62B0.64$67.74M-$0.38-35.05

Integer presently has a consensus target price of $145.56, suggesting a potential upside of 19.79%. Integra LifeSciences has a consensus target price of $18.63, suggesting a potential upside of 39.83%. Given Integra LifeSciences' higher possible upside, analysts clearly believe Integra LifeSciences is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Integra LifeSciences
4 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.78

In the previous week, Integer had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 12 mentions for Integer and 8 mentions for Integra LifeSciences. Integer's average media sentiment score of 1.12 beat Integra LifeSciences' score of 0.70 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integra LifeSciences
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 2.2% of Integer shares are held by insiders. Comparatively, 3.5% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Integra LifeSciences received 44 more outperform votes than Integer when rated by MarketBeat users. However, 63.92% of users gave Integer an outperform vote while only 56.72% of users gave Integra LifeSciences an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
395
63.92%
Underperform Votes
223
36.08%
Integra LifeSciencesOutperform Votes
439
56.72%
Underperform Votes
335
43.28%

Summary

Integer beats Integra LifeSciences on 13 of the 18 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IART vs. The Competition

MetricIntegra LifeSciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.04B$4.54B$5.43B$8.48B
Dividend YieldN/A43.65%5.22%4.11%
P/E Ratio-147.9829.8726.7920.05
Price / Sales0.6470.43394.72116.44
Price / Cash4.5651.0838.2534.62
Price / Book0.666.346.864.61
Net Income$67.74M$67.64M$3.22B$248.19M
7 Day Performance3.10%21.94%6.83%2.97%
1 Month Performance-12.31%26.54%13.73%16.58%
1 Year Performance-51.35%22.75%18.22%8.16%

Integra LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IART
Integra LifeSciences
4.4555 of 5 stars
$12.69
-4.7%
$18.63
+46.8%
-50.6%$986.17M$1.62B-140.983,720Gap Up
ITGR
Integer
2.7017 of 5 stars
$120.50
+1.7%
$145.56
+20.8%
+1.1%$4.20B$1.75B35.8610,000Analyst Upgrade
Analyst Revision
ATEC
Alphatec
4.1567 of 5 stars
$12.67
+3.8%
$17.89
+41.2%
+17.6%$1.85B$642.27M-9.90700Positive News
ATRC
AtriCure
3.63 of 5 stars
$31.81
+2.6%
$50.67
+59.3%
+52.6%$1.57B$480.08M-33.481,050Positive News
OFIX
Orthofix Medical
3.4572 of 5 stars
$12.43
+2.6%
$23.33
+87.7%
-20.6%$485.04M$804.53M-3.971,090Positive News
ANGO
AngioDynamics
4.5285 of 5 stars
$9.57
+5.0%
$14.00
+46.3%
+63.7%$388.61M$283.32M-1.70760News Coverage
Positive News
SRDX
Surmodics
4.2927 of 5 stars
$27.09
+1.2%
$43.00
+58.7%
-15.3%$387.36M$121.58M-26.82450Positive News
ARAY
Accuray
2.1518 of 5 stars
$1.66
+9.9%
N/A+8.7%$171.00M$465.25M-33.201,040Analyst Downgrade
RMTI
Rockwell Medical
4.1224 of 5 stars
$1.04
-7.1%
$4.00
+284.6%
-40.6%$35.54M$101.49M-20.80300Analyst Revision
RSLS
ReShape Lifesciences
0.5653 of 5 stars
$6.01
-9.8%
N/A-98.1%$2.71M$8.01M-0.0250News Coverage
Earnings Report
Gap Down
ABT
Abbott Laboratories
4.8818 of 5 stars
$131.90
-1.0%
$142.59
+8.1%
+30.9%$229.49B$42.34B17.24115,000News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:IART) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners